OAC
SAGE

OMERS Administration Corp’s Sage Therapeutics SAGE Stock Holding History

OMERS Administration Corp’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-424,300
Closed -$3.87M – 1205
2025
Q2 		$3.87M Buy
+424,300
New +$3.12M 0.03% 202

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

OMERS Administration Corp's SAGE Position: Q3 2025 in Review

OMERS Administration Corp sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 424,300 shares — an estimated $3.87M sold.

OMERS Administration Corp first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $3.87M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • OMERS Administration Corp reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 424,300 Sage Therapeutics shares in Q3 2025, an estimated $3.87M.
  • OMERS Administration Corp first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Sage Therapeutics position peaked at $3.87M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on OMERS Administration Corp's 13F filing for Q3 2025, filed 14 Nov 2025.